Shandong Sito Bio-technology Co., Ltd. (300583.SZ)

CNY 20.86

(3.52%)

Market Cap (In CNY)

3.95 Billion

Revenue (In CNY)

1.27 Billion

Net Income (In CNY)

45.6 Million

Avg. Volume

4.63 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
10.66-31.63
PE
-122.71
EPS
-0.17
Beta Value
0.169
ISIN
CNE100002F36
CUSIP
-
CIK
-
Shares
189702000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Fuwen Li
Employee Count
-
Website
https://www.sitobiotech.com
Ipo Date
2017-01-09
Details
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal, acid removal, 3-ketal, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.